£1.0M
The company has obtained capital from the NHS England funded initiative to support pre-clinical development.
C
Chondrogenix
Chondrogenix develops regenerative cartilage therapy for osteoarthritis patients.
£1.0MTotal raised
Chondrogenix is a biotechnology company developing regenerative cartilage therapy for the treatment of osteoarthritis. The firm uses a data driven conversion platform to generate a scalable source of therapeutic cells.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Net assets
Members only
Shareholders' funds
Members only
Current assets
Members only
Employees
Members only
Cash, assets and headcount from Chondrogenix's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
WK
Wael Kafienah
Director